Progress and Perspective in the Treatment of Lung Cancer

Prijzen vanaf
144,99

Uitgelicht

VERGELIJK ALLE AANBIEDERS (1)

Beschrijving

Bol In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. This volume documents the progress that has been made in the treatment of lung cancer, examining in detail the applicability and use of the various therapeutic modalities. Emphasis is placed on the benefits of a multimodality approach to lung cancer, and the editors have sought to achieve a balance between the perspectives offered by US and European authors. The comprehensive coverage of the subject and the expertise of the authors ensure that the volume will be of widest interest. This volume documents the progress that has been made in the treatment of lung cancer, examining in detail the applicability and use of the various therapeutic modalities. Emphasis is placed on the benefits of a multimodality approach to lung cancer, and the editors have sought to achieve a balance between the perspectives offered by US and European authors.

Vergelijk aanbieders (1)

Sorteren op:

€ 149,99 € 144,99 Gratis verzending

Beschrijving (1)

In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. This volume documents the progress that has been made in the treatment of lung cancer, examining in detail the applicability and use of the various therapeutic modalities. Emphasis is placed on the benefits of a multimodality approach to lung cancer, and the editors have sought to achieve a balance between the perspectives offered by US and European authors. The comprehensive coverage of the subject and the expertise of the authors ensure that the volume will be of widest interest. This volume documents the progress that has been made in the treatment of lung cancer, examining in detail the applicability and use of the various therapeutic modalities. Emphasis is placed on the benefits of a multimodality approach to lung cancer, and the editors have sought to achieve a balance between the perspectives offered by US and European authors.


Productspecificaties

EAN
  • 9783540625483
  • 9783642641404
Maat


Prijshistorie

Prijzen voor het laatst bijgewerkt op:

Uitgelichte Keuze
144,99
Naar shop